[HTML][HTML] Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell …
JN Weiss, SC Benes, S Levy - Neural regeneration research, 2016 - journals.lww.com
We report results in a 77-year-old male patient with visual loss from long-standing
serpiginous choroidopathy treated with bone marrow derived stem cells (BMSC) within the
Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review
Board approved clinical trial and the largest ophthalmology stem cell study registered at the
National Institutes of Health to date (ClinicalTrials. gov Identifier: NCT01920867). Eight
months after treatment by a combination of retrobulbar, subtenon, intravitreal and …
serpiginous choroidopathy treated with bone marrow derived stem cells (BMSC) within the
Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review
Board approved clinical trial and the largest ophthalmology stem cell study registered at the
National Institutes of Health to date (ClinicalTrials. gov Identifier: NCT01920867). Eight
months after treatment by a combination of retrobulbar, subtenon, intravitreal and …